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ABSTRACT 
The most well characterized eukaryote model organism Saccharomyces cerevisiae is not only preferred as a 
microbial cell factory for synthesis of industrial products, e.g. bioethanol, but this eukaryote host system is also 
defined as a robust scaffold for commercial production of diverse chemicals e.g. isoprenoids. Therefore, a 
number of tools in different emerging fields e.g. systems biology, evolutionary engineering and synthetic biology 
have been developed. Synthetic biology offers an alternative approach that is becoming more accessible as a tool 
for better performing metabolic engineering of yeast. Due to the fact that the regulations of gene dosage and 
gene transcription are the first two key steps allowing control of metabolic pathways, improve of both gene 
expression and gene dosage through modulating promoter choice and plasmid copy number were pursued. The 
strength of seven different constitutive or glucose based promoters, TEF1, PGK1 TPI1, HXT7, PYK1, ADH1 and 
TDH3, was compared at different stages of a batch cultivation using LacZ as reporter. A new divergent promoter 
was developed, containing two strong and constitutive promoters, TEF1 and PGK1, to support high level gene 
expression. Furthermore, this bidirectional promoter was used to construct new episomal plasmids, the pSP 
series, to optimize the endogenous mevalonate (MVA) pathway through gene overexpression and also to 
construct integration cassettes containing the synthetic methylerithritol phosphate (MEP) pathway genes. The 
last two studies showed the successful implementation of synthetic biology tools in metabolic engineering in 
terms of pathway optimization and pathway reconstruction in order to improve sesquiterpene production in S. 
cerevisiae. Optimization of the MVA pathway was performed in two steps, modulating the FPP branch point and 
modulating the possible nodes which are directly involved or related to the MVA pathway including 
overexpression of tHMG1, ERG20, GDH2 and upc2-1 and deletion of GDH1, DPP1 and LPP1. Combination of 
all these modifications led to a 4-fold improvement of α-santalene yield over the reference strain. In the second 
study, the bacterial MEP pathway, containing 8 genes, was reconstructed through stable integration into the yeast 
genome in two steps. However, a functional MEP pathway was not obtained even after reconstruction of the 
possible bacterial Fe/S trafficking routes and the bacterial electron transfer system in order to circumvent lack of 
the enzyme activity. In another approach, improvement of gene dosage via modulating plasmid copy number 
was investigated. Here, two strategies, individually and in combination,were applied in order to reduce the maker 
gene at both protein and RNA levels, and their impact on plasmid copy number of pSP-GM1was investigated. 
Both methods, destabilization of the marker protein using a ubiquitin/N-degron tag and down-regulation of the 
marker gene employing weak promoters, elevated the plasmid copy number. Combination of the weak promoter 
and ubiquitin tag showed a synergistic effect and increased the plasmid copy number by 3 fold. A proof-of-
concept study was performed to determine if the enhancement in plasmid copy number could affect patchoulol 
production when patchoulol synthase was expressed from the modified plasmid. The result showed that while 
the final biomass concentration was unchanged, patchoulol production reached about 30 mg/L when employing 
modified plasmid, which was more than 3 times higher compared to when the synthase gene was expressed from 
the original plasmid. 
 
Key words: S. cerevisiae, Synthetic biology, Metabolic engineering, Yeast promoter, MVA pathway, MEP 
pathway, Fe – S clusters, Multi-copy plasmid.  
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CHAPTER 1:  INTRODUCTION 
 
1.1.1. Introduction to synthetic biology and its impact on metabolic engineering of yeast  
The engineering of biological systems has enormous power to reshape the world in various fields, such 
as sustainment of all systems, environmental rehabilitation, and manufacturing at all macro- and 
micro-levels, preventative and curative health issues and general medicine. Synthetic biology is 
advancing capabilities for engineering biological systems through employing engineering principles 
and novel biological tools to the process of constructing and implementing human-designed biological 
systems, and to predictably produce a wide variety of pathways and regulatory networks. These 
innovations have offered a variety of applications in metabolic engineering of microorganisms aiming 
to give them new abilities which are not inherent to the microorganism, e.g. production of artemisinic 
acid in engineered yeast (Ro et al., 2006), production of n-butanol in Saccharomyces cerevisiae (Steen 
et al., 2008), enhancements in production of fatty acid derived biofuels by using dynamic sensor-
regulator system in E. coli (Zhang et al., 2012) and modulation of metabolic flux using synthetic 
protein scaffolds (Dueber et al., 2009). In the latter study, the authors presented synthetic protein 
scaffolds to physically emplace metabolic enzymes involved in the mevalonate biosynthetic pathway 
together. Using these synthetic protein scaffolds a dramatic enhancement was observed in mevalonate 
production due to substrate tunneling mechanisms by which metabolites moved quickly from one 
active site to another, without loss by diffusion or degradation (Dueber et al., 2009). These are few 
examples which have shown the implementation of genetic engineering and synthetic biology in 
metabolic engineering and have demonstrated the ability of synthetic biology to provide an alternative 
to traditional methods in order to transplant the genes related to biosynthetic pathways from natural 
hosts into heterologous hosts such as E. coli or S. cerevisiae.  
Similar to E. coli, among the eukaryote host systems, yeast contains the benefits of unicellular 
organisms i.e., the amenability for genetic manipulations and cell culture. It has also high capability 
for protein processing i.e., post-translational modifications and protein folding. These benefits are 
combined with a deep knowledge about yeast physiology, biochemistry and fermentation 
technologies, and also the lack of endotoxin production, as well as oncogenic or viral DNA-made 
yeast, S. cerevisiae, as suitable organism which has been widely used for heterologous expression of 
biochemical pathways in the field of pathway engineering and metabolic engineering (Szczebara et al., 
2003; Yan, Kohli, & Koffas, 2005; Ro et al., 2006; Dejong et al., 2006). Furthermore, due to its 
importance in traditional biotechnology such as baking, brewing and wine making, S. cerevisiae has 
been classified as GRAS (generally regarded as safe) and many research activities, historically, have 
focused on this organism. It was the first eukaryotic organism to have its genome completely 
sequenced (Goffeau et al., 1996). Besides the aforementioned advantages, S. cerevisiae is known as a 
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eukaryotic model organism because of two important criteria. First, it is a single celled organism with 
a short generation time (doubling time of 1.25–2 hours) and it can be easily cultured in both 
rich/complex and minimum/synthetic media. Second, S. cerevisiae can be transformed through 
homologous recombination, allowing for genetic manipulation such as knockout or mutation of native 
genes, changing the expression level of a desired gene, or insertion of a heterologous gene. These 
fundamental knowledge bases have led to the development of a number of tools in different emerging 
fields e.g. systems biology, evolutionary engineering and synthetic biology. Among them, synthetic 
biology offers an alternative approach that is becoming more accessible as a tool for improved 
metabolic engineering of yeast. Along this line, there will be discussed important synthetic biology 
tools developed for controlling enzyme expression levels and the progress in DNA transformation 
methods in yeast in this chapter. And finally, a short introduction to isoprenoid production through 
both MVA and MEP pathways will be considered.  
 
1.2. Synthetic biology tools for controlling enzyme expression levels 
From an economic point of view, high productivities, titers and yields are essential for microbial 
production of chemicals. Optimizing pathway flux, reducing toxic intermediates, and balancing stress 
on the cell are the most important factors required to reach maximal yields. Therefore, pathway 
optimization and, specifically, modulation of enzyme expression is the focus and is one of the key 
challenges in most metabolic engineering investigations aiming at production of fine chemicals and 
pharmaceuticals. Recent advancements in synthetic biology offer a set of novel tools which are useful 
for controlling enzyme expression levels (Siddiqui et al., 2012). In spite of the diversity, these tools 
attempt to modulate at process units of central dogma like transcription or translation leading to 
altered levels of central components, e.g. DNA, RNAs and proteins (Figure 1). In 1958 Francis Crick 
described the Central Dogma. This principle describes a framework which is useful for understanding 
the way of biological information. In addition to the three major process units (DNA replication, 
transcription and translation), many other sub-processes have been declared in last two decades, e.g. 
splicing, which is the process for modifying RNA molecules after transcription, and different types of 
post-translational processes, which is the chemical modification of protein molecules after translation. 
Understanding the principle of each process in the central dogma will enhance our ability to design 
novel tools to control the biological processes, which are performed inside the living cell, at a 
predictable level. As mentioned before, different and advanced biological tools have been developed 
for optimizing of biochemical pathways. In the following, the mechanisms of these biological 
apparatuses will be described with specific consideration of yeast, as the major eukaryotic model 
organism.      
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Figure 1: The central dogma; Arrows represent the process units containing (A) transcription process, (B) post-
transcription process, (C) translation process and (D) post-translation process. 
 
1.2.1. Synthetic biology tools at DNA level 
DNA, which is coding the mystery of life, is the first component in the central dogma. Therefore, 
several toolsets have been developed for tuning expression of either endogenous or heterologous genes 
at the DNA level, and especially in yeast. Basically, they aim at altering gene copy number or gene 
dosage e.g., plasmid DNA and yeast artificial chromosomes (YAC) (Murray A. W, 1983) or offer an 
accurate control over gene copy number and stability, e.g., integration of heterologous gene via 
homologous recombination (Shao et al., 2009; Hawkins & Smolke, 2010) (Figure 2). 
As in E. coli, different plasmids have been modified for yeast, while their availability for use in yeast 
is much more limited than those for E. coli. These plasmids have been successfully applied in 
metabolic engineering investigations (Ro et al., 2006)(Maury et al., 2008). Yeast plasmids are 
classified into three different classes, YCp, YEp and YIp (Figure 2) (Silva & Srikrishnan, 2012). YCp 
and YEp have been employed for many applications. YCp (yeast centromeric plasmid) vectors contain 
both an origin of replication and a centromere sequence. These two elements give YCp vectors high 
segregation stability in selective medium, while maintaining 1-2 copies per cell (Clarke & Carbon 
1980). YEp (yeast episomal plasmid) vectors are maintained at more than 10 copies per cell (Romanos 
et al., 1992). This type of vector harbors either a full version of S. cerevisiae native 2µ sequence or 
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commonly, a 2µ sequence including both the origin and the stability locus (STB), REB3  (Futcher & 
Cox, 1983; Kikuchi 1983). The latter ones are generally more stable in comparison to those which are 
carrying full 2µ sequence.  
 
Figure 2: Different synthetic biology tools developed at DNA level. A: yeast centromeric plasmid (YCp); B: 
yeast episomal plasmid (YEp); C: yeast integrative plasmid (YIp); D: yeast artificial chromosome (YAC)  
  
Besides, the plasmid copy number can be modulated through the engineering of other elements on the 
plasmid such as the auxotrophic marker. For example, replacing the native promoter region of plasmid 
auxotrophic markers URA3 and LEU2 with the truncated and weak promoters URA3-d and LEU2-d, 
respectively, resulted in enhancement of the plasmid copy number (Erhartt & Hollenberg, 1983; 
Loision et al., 1989). Faulkner and co-workers (1994) had been able to improve the plasmid copy 
number to 150 and 111 copies per cell by using the URA3-d and LEU2-d marker, respectively 
(Faulkner et al., 1994). This type of plasmid with high copy number is recommended for 
overexpression of a product gene, rather than pathway optimization and metabolic engineering 
purposes (Jones et al., 2000). Despite over-expression of enzymes, results of such a high copy number 
may cause the depletion of precursors or resources, which are necessary for growth and production 
(Glick, 1995).  
The third class of yeast vectors are YIps, yeast integrative plasmids, which do not have any replication 
origin. Therefore, they need to be integrated into the chromosome in order to maintain them in the cell. 
YIp vectors can be integrated into the genome via homologous recombination occurring between 
complementary target sites on both plasmid and genome. Different target sites have been developed 
for YIp vector series e.g., auxotrophic markers which offer integration by single-crossover (Gietz & 
Sugino, 1988; Cartwright et al., 1994a; Alberti et al.,, 2007; Sadowski et al., 2007). Table 1 illustrates 
several vector series in all three classes.  
Both YCp and YEp vectors are uncomplicated to use and are ideal for gene overexpression at low or 
high levels. Although plasmids offer a quick appraisal of the degree of overexpression, which is 
necessary in a metabolic pathway, the maintenance of two or more YCp (CEN/ARS) and/or YEp (2µ) 
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vectors for stable existence in a single cell can be difficult. In addition, the use of plasmids is limited 
to carry small size of DNA molecule. However, this limitation is circumvented by employing yeast 
artificial chromosomes (YAC) which offer the possibility to transference large DNA molecule (more 
than several Mbps) (Murray A. W, 1983; Kouprina & Larionov, 2008).  
YAC constructs, as YCp and YEp, require a selective pressure, in order to be maintained in long term 
cell culture. On the other hand, chromosomal gene integration is efficient in yeast. This natural ability 
serves a robust expression platform, which allows highly stable maintenance in free-continuous 
selective pressure. Thus, different methods have been developed, based on this stable integration and 
they have been successfully employed, either for optimization of endogenous metabolic pathways (Ro 
et al., 2006) and/or transformation of heterologous pathways (Szczebara et al., 2003; Shao et al., 2009) 
which will be discussed later in this chapter. 
 
1.2.2. Tools for control of the transcription level  
Because most biological processes are regulated at the level of transcription as the first dedicated 
phase of gene expression (Sikder & Kodadek, 2005), the second toolset for controlling gene 
expression is, basically, developed for tuning transcription level. Based on these facts, different 
toolsets have been developed for modulating RNA levels in the cell and are classified into two groups. 
The first group modulates directly the RNA level during the synthesis process of this molecule 
performed by RNA polymerase e.g., employs different promoters with promising desired effects, and 
the second group controls the stability of RNA after being synthetized. The latter is defined as an RNA 
control device (Liang et al.,, 2011; Chang et al., 2012).  
A: Control of transcription process  
Promoters, which are a target for RNA polymerase, are one of the main regulatory elements 
controlling RNA synthesis and so they can play a significant role in modification of toolsets employed 
for tuning transcription level and also are potential target application in synthetic biological circuits 
(Ajo-Franklin et al., 2007; Bashor et al., 2008). Ajo-Franklin and co-workers presented a yeast 
memory device, which is controlled at the transcription level using two promoters GAL1/10 and 
minimal CYC1 (Ajo-Franklin et al., 2007). In another example, a synthetic feedback loop has been 
created for modulating the MAP kinase pathway through employing different modulators whose 
expression was controlled with constitutive or inducible promoters (Bashor et al., 2008). 
There are approximately 6000 promoter regions which have been found in S. cerevisiae, according to 
SCPD (The Promoter Database of S. cerevisiae: http://rulai.cshl.edu/SCPD). These promoters are 
classified into two categories, constitutive and regulatable (Figure 3), however, different promoter 
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libraries and chimeric promoters have been recently developed, employing DNA manipulation 
methods (Jensen, 2003; Alper et al., 2005; Zhang et al., 2012). Alper and co-workers have generated a 
promoter library of constitutive promoter TEF1, introducing mutations into the sequence of this 
promoter via error-prone PCR (Alper et al., 2005). They demonstrated a series of TEF1 promoters 
with activity range of 17 to 250% of the original.  
Promoters with constant activity have been widely employed for modulating gene expression in S. 
cerevisiae. These promoters usually apply in a simple manner, which makes it not necessary to use 
additional molecules as inducers or repressors and they provide closely constant levels of gene 
expression. These features make them favored for the introduction of new pathways in yeast, 
especially if active pathways are desired during cell growth. Most of the yeast glycolytic pathway 
genes in S. cerevisiae are controlled by constitutive promoters, e.g., TDH3, PGK1, PYK1 and TPI1. 
They have been widely used to construct expression cassettes of different plasmids (Table 1.1), 
allowing high expression levels during long-term cell culture.  
Although applying strong and constitutive promoters results in radical changes in target gene 
transcript levels, regulated promoters have an advantage of controlling the expression level of the 
specific gene in response to changing concentrations of specific molecules, either inducer or repressor. 
A small number of regulated promoters have been found and employed in yeast. The most important 
are GAL1 and GAL10, which are induced in the presence of galactose and repressed using glucose as a 
carbon source (Lohr et al., 1995). MET25 (Sangsoda et al., 1985), MET3 (Cherest et al., 1985) and 
CUP1  (Etcheverry, 1990) promoters which are responding to the presence of methionine and copper, 
respectively, are another example of yeast native regulated promoters. In order to redirect the flux of 
farnesyl diphosphate (FPP) to produce sesquiterpenes, the MET3 promoter has successfully been 
employed in down-regulation of ERG9 encoding squalene synthase (SQS) (Ro et al., 2006; Asadollahi 
et al., 2008). The Tet promoter is an example of a synthetic bacterial regulated promoter which is 
adapted for use in S. cerevisiae and which is induced by the antibiotic tetracycline (Dingermann et al., 
1992).  
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Regulated promoters have many advantages, e.g., there are easy employment, support well-defined 
and predictable expression levels and are also a useful tool for verifying the optimal expression level 
of a particular enzyme in a metabolic network (Westfall et al., 2011; Hawkins & Smolke, 2010). 
However, inducer or repressor molecules may show pleiotropic effects (Mumberg et al., 1994; Wishart 
et al., 2005; Labbe & Thiele 1999) or may be consumed by the cell, which both make it complicated 
system to control the expression level. In addition, the inducer molecules are typically expensive, and 
using inducible promoters may not be economical for industrial-scale fermentations. 
 
Figure 3: Schematic representation of expression level at transcription, which is controlled by different types of 
promoters. Promoters are orang chevrons, coding region are red pentagons, pies with different colors represent 
proteins, blue and green stars represent inducer and repressor molecules, respectively. A: constitutive promoter; 
B: regulated promoter; C: promoter library   
  
MGPA (multiple-gene-promoter-shuffling) offers a useful tool for metabolic engineering purposes (Lu 
& Jeffries, 2007). This tool has been implemented to optimize xylose fermentation in yeast. The rate-
limiting steps of the pentose phosphate pathway (PPP) have been modulated by employing the 
combination of multiple promoters with different strengths. The authors have demonstrated that the 
best ethanol production has been achieved via the optimal expression level of limiting steps of this 
pathway. Instead of constitutive or inductive expression, in metabolic engineering approaches the 
combination of different promoters is recommended in order to balance metabolic pathways.  
B: RNA control devices 
RNA molecules play varying functional roles in living cells e.g., regulation of gene expression 
through RNA secondary structure, catalytic activity (ribozyme) with functional roles in RNA 
replication, RNA stability, splicing and translation in both prokaryotes and eukaryotes (Serganov & 
Patel, 2007) and regulate protein synthesis through antisense-mediated regulation of translation. Due 
to these facts, recently different synthetic RNA switches with diverse roles including sensing, 
regulatory, information processing and scaffolding activities have been developed in order to aid 
programming of biological systems. These synthetic RNA switches are, generally, composed of two 
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domains. First, is the sensing domain that detects signals inside a cell (input) and second is the 
actuator domain that alters gene expression. In some cases, a distinct transmitter domain adds to the 
RNA switch in order to provide better communication between sensing domain and actuator domain 
(Figure 4). Based on the type of regulated process, RNA switches are divided into five different 
categories: transcription-modulation, splicing-modulation, RNA stability-modulation, RNA 
interference-modulation, translation-modulation and post translation-modulation switches (Chang et 
al., 2012). From these, different RNA switches for modulating biological systems at transcription, 
splicing and RNA stability level have been developed in S. cerevisiae (Buskirk et al., 2004; Weigand 
& Suess, 2007; Win & Smolke, 2007; Win & Smolke, 2008; Babiskin & Smolke, 2011a; Babiskin & 
Smolke, 2011b). In a recent study, Babiskin and Smolke added the synthetic Rnt1p hairpin, which is a 
target of RNase III at the 3´ UTR of ERG9, in order to control its expression (Babiskin & Smolke, 
2011b). The ability of this posttranscriptional control device in reducing the expression of ERG9, has 
been demonstrated through comparing the transcription level of ERG9 in strains carrying this module 
and wild type (Babiskin & Smolke, 2011b). The authors suggested that this new controlling system 
has a benefit, to systematically titrate pathway enzyme level while keeping cellular control strategies 
active. 
 
1.2.3. Tools for control at the protein level  
Proteins are the curtail players inside the cell and most biological activities are well-controlled by the 
functions of different proteins e.g., enzymatic activity, signaling and transporting, and structural 
proteins. The level of these multi-functional macromolecules plays an important role in modulating 
biological systems. During the last decade, different protein-based control elements acting through 
protein degradation have been developed and employed for tuning protein levels (Mateus & Avery, 
2000; Hackett et al., 2006; Grilly et al., 2007). These elements usually alter the protein half-lives to 
provide rigid dynamic regulation over biochemical pathways.  
The fundamental importance of these elements is to introduce a degradation tag signal at the N- or the 
C- terminus of target protein(s), leading them into the natural degradation machinery of the cell, e.g. 
ubiquitination in yeast which serves as an exquisite process for control of protein degradation (Figure 
4). For example, Mateus and Avery (Mateus & Avery, 2000) have constructed a new destabilized 
green fluorescent protein by fusing the C-terminal residues of yeast G1 cyclin, Cln2p into yeast-
optimized GFP (yEGFP3). The residues of Cln2p contain the PEST motifs of Cln2 and are anticipated 
to target the protein for ubiquitin (Ub) - dependent degradation. They have shown that the new and 
modified GFP is efficiently unstable and it can be implemented for monitoring dynamic changes in 
yeast gene expression (Mateus & Avery, 2000). It has also been shown that modification of the S. 
cerevisiae N-degron signal sequence can influence reporters half-life and bring it down to 2 min 
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(Hackett et al., 2006). Grilly and coworkers have constructed a synthetic protein degradation network 
in S. cerevisiae (Grilly et al., 2007). They have adapted the prokaryotic ssrA tagging system in S. 
cerevisiae by importing an E. coli degradation machinery, ClpXP protease. The reduction of the half-
life of GFP to as low as 22 min has been observed by employing ClpXP protease (Grilly et al., 2007). 
In contrast to other tagging systems, aforementioned, (Mateus & Avery, 2000; Hackett et al., 2006), 
the latter example offers a tunable protein degradation system with less undesired pleiotropic effects in 
yeast. 
In addition to the presented protein toolsets, different internal ribosome entry sites (IRES) have been 
reported in yeast, which have influence on protein expression (Zhou et al., 2001). Furthermore, a 
library of internal ribosome entry sites (IRES) have been developed (Zhou et al., 2003). Recent 
elements may offer a promising device for controlling protein expression in the future and also they 
can potentially be applied to construct polycistronic gene clusters in eukaryotic systems such as yeast. 
 
Figure 4: Schematic representation of synthetic biology tools developed for modulating protein stability. 
Promoters are orange, coding region are red pentagons, red pies represent protein, green boxes are peptide tag at 
C- and N- terminal, respectively; (A) non-tagged protein; (B) C-tagged protein; (C) N-tagged protein  
 
1.3. Synthetic biology and re-construction of metabolic pathways in S. cerevisiae 
The first step of most yeast metabolic engineering and synthetic biology studies aiming at design and 
construction of cell factories indicating non-native and desirable traits, is to reconstruct a completely, 
or partially, synthetic pathway. So, stable assembly and transfer of heterologous pathways with several 
enzymatic steps is a major challenge in metabolic engineering. Several methods have been developed 
which can be used for transferring DNA into S. cerevisiea as a desired host. Each of them has benefits 
and disadvantages. Here, I classify these methods into three categories: (i) Plasmid-based methods, (ii) 
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YAC-based methods for transferring DNA and (iii) DNA transfer through chromosomal integration. 
The principle of this classification is based on progression in DNA assembling methods.  
 
1.3.1. Plasmid-based method for transferring DNA  
Yeast plasmids offer a simple tool for transferring DNA sequences. Essentially, this method is 
developed based on restriction and ligation, in order to clone the desired ORF (insert) into a vector. 
Hence, finding at least one unique restriction site in both plasmid and DNA insert is the first necessary 
requirement which highlights the first limitation of this method. On the other side, yeast does not 
naturally express polycistronic operons like prokaryotes, which means that each gene requires its own 
promoter and terminator flanking sequences. The latter raises the requirement for a different set of 
promoters and terminators for cassette assembly and it can increase the size of the plasmid. These 
issues limit the application of either YEp or YCp for transferring a small number of genes e.g. two 
genes instead of a whole metabolic pathway containing several steps. In addition, maintenance of the 
plasmid requires selective media which can result in incomplete selection of cells for long-term 
cultivation. However, in spite of such limitations, episomal plasmids have successfully been employed 
to reconstruct the bacterial MEP pathway in S. cerevisiae (Maury et al., 2008). The seven enzymatic 
steps of the MEP pathway carried on two episomal plasmids were transformed into yeast.  
 
1.3.2. YAC-based method for transferring DNA 
Due to its high efficiency and ease to work with in vivo homologous recombination in Saccharomyces 
cerevisiae, different synthetic biology tools were developed for stable transfer of metabolic pathway 
steps containing large amounts of DNA sequences, e.g., yeast artificial chromosomes (YAC) (Murray 
A. W, 1983). YACs have been employed in reconstruction of a flavonoid pathway in S. cerevisiae 
(Naesby et al., 2009). Genes from different organisms encoding enzymes of a flavonoid pathway have 
individually been cloned to make a full expression cassette containing promoter and terminator and, 
furthermore, all cassettes randomly assembled on Yeast Artificial Chromosomes to construct the 
flavonoid pathway (Naesby et al., 2009). Kouprina and Larionov (2008) have developed a new 
protocol which is based on transformation-associated recombination (TAR) in S. cerevisiae employing 
TAR-cloning vector compassing targeting sequences homologous to a desirable region (Kouprina & 
Larionov, 2008). This method allows for transferring up to 250 kb of selective DNA sequences in size 
as a circular yeast artificial chromosome (Kouprina & Larionov, 2008). In another example, Gibson 
and co-workers (2008) have demonstrated assemblage of the Mycoplasma genitalium genome (582970 
bp) in S. cerevisiae in 4 steps using a combination of both in vitro enzymatic assembly and in vivo 
TAR-based cloning (Gibson, Benders, Andrews-pfannkoch, et al., 2008). Later, the same research 
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group reported the successful one-step assembly of the entire synthetic bacterial genome consisting of 
25 overlapping DNA constructs in yeast (Gibson et al.,, 2008). The methods described above are 
mainly based on in vivo DNA assembly which is operated efficiently by yeast because of its high 
potential for homologous recombination. Recently, an organisms-independent method has been 
developed, offering an in vitro assembly of large DNA sequences (Gibson et al., 2009). In contrast to 
the two-step thermocycled DNA assembly (Gibson et al., 2008), the one-step isothermal DNA 
assembly can be efficiently used to construct up to several hundred kilobases of DNA fragment by 
using a mixture of enzymes including 5’ exonuclease, DNA polymerase and DNA ligase in a single 
reaction (Gibson et al., 2009). In spite of successful assembly and transformation shown by these 
examples, the maintenance of such systems still requires selective pressure, provided by using 
selective media. 
 
1.3.3. DNA transfer through chromosomal integration  
Via homologous recombination large sizes of DNA can be integrated into the chromosome. Based on 
this natural ability different methods have been developed, aiming at heterologous DNA transfer into 
yeast e.g., DNA assembler (Shao et al., 2009). DNA assembler enables design and fast construction of 
large biosynthetic pathways in S. cerevisiae on both plasmids and by integration into the chromosome. 
Employing this method, Shoa and co-workers (2008) have demonstrated rapid assembly of a 
functional D-xylose utilization pathway consisting of 3 genes (≈9kb), a zeaxanthin biosynthetic 
pathway including 5 genes (≈11kb) and combined both pathways (≈19kb) with an efficiency of 70-
100%, either on plasmid or on a chromosome (Shao et al., 2009). Later, this method has been 
improved to easily perform genetic manipulations such as site-direct mutagenesis without going 
through the complicated multi-step procedures, and scar-less gene substitution and deletion which is 
useful for studying gene function (Shao & Zhao, 2011). The existence of target sites allowing efficient 
integration via crossing-over and also suitable selection markers for easily isolating correct 
transformants are two limitations of this method. However, the latter is circumvented by using a 
reusable selection marker, which allows multiple sequential gene transformation via homologous 
recombination. cre/loxP and FLP/FRT are the most famous examples of marker recycling systems 
with wide applications in yeast (Sauer, 1987; Güldener et al., 1996; Gueldener et al., 2002; 
Radhakrishnan & Srivastava, 2005).  
“Reiterative recombination” is a robust DNA manipulation method developed for direct integration 
into the yeast chromosome by Wingler and Cornish (Wingler & Cornish, 2011). The key point of this 
method is based on utilization of recyclable marker and endonuclease-stimulated homologous 
recombination offering an efficient and simple procedure for sequentially building large libraries of 
biosynthetic pathways in vivo (Wingler & Cornish, 2011). Although this method has been developed 
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in yeast, it can be used in other organisms which have endogenous or engineered recombination 
systems. 
Nowadays de novo DNA synthesis, especially in combination with codon optimization algorithms 
offer cheap and efficient tools for DNA manipulations. Through the progression in constructing 
metabolic pathway, using codon optimization algorithms provide inputs, e.g. genes with more 
efficiently translated heterologous host, subsequently, can improve the activities of pathway enzymes 
as efficiently as with native gene sequences (Redding-Johanson et al., 2011). Therefore, combining 
advanced methods for DNA transformation with the latest progression in DNA synthesis can improve 
not only DNA manipulation, but it may also improve protein activity. Figure 5 illustrates progress in 
DNA assembly methods.  
 
Figure 5: Schematic representation of assembly methods for forming DNA constructs; (A) Plasmid-based based 
on restriction and ligation; (B) chromosomal integration based in vivo homologous recombination; (C) YAC-
based method based on both in vivo or in vitro homologous recombination. 
 
1.4. Biosynthesis of isoprenoids compounds  
Isoprenoids are a large group of natural and chemical compounds with more than 50,000 known 
members. Besides their varied essential biological functions, e.g. cell membrane fluidity (steroids), 
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respiration (quinones), hormones (abscisic acid), protein regulation (glycosylation), isoprenoids have 
valued applications e.g. as fragrances, pharmaceuticals and potential biofuels  (Kirby and Keasling 
2009; Zhang et al., 2011). Although all organisms use isoprenoids for their basic cellular processes, 
these compounds are found in high variability in plants and play essential roles in specialized 
processes such as defense, pollinator attraction, communication and involvement in growth and 
development. However, extraction of these compounds from plants needs a massive amount of raw 
material and usually suffers from low yield. For example, about six 100-years old Pacific yew trees are 
needed for producing a sufficient amount of taxol (anti-cancer) required for treatment of one patient 
(Horwits, 1994). In addition, chemical synthesis and production of these natural compounds can be 
extremely difficult because of structural complexity which is important for their activity. Due to these 
facts, the use of microorganisms like E. coli or S. cerevisiae for producing heterologous isoprenoids is 
an attractive approach, both environmentally and economically.  
Despite the diversity, all isoprenoids are derived from five carbon isoprene units (2-methyl-1, 3-
butadiene) and depending on the number of isoprene units in carbon skeleton different groups of 
isoprenoids are formed (Maury, Asadollahi, & Møller, 2005). Isopentenyl diphosphate (IPP), which is 
the universal biological precursor for all isoprenoids, is produced via two different metabolic 
pathways, the mevalonate (MVA) pathway, which is operational in eukaryotic cells and the cytoplasm 
and mitochondria of plants, and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway, which is 
specific to bacteria, other prokaryotes and the plastids in plants (Maury et al., 2005; Kirby and 
Keasling 2009).  
 
1.4.1. Mevalonate pathway  
As described in Figure 6, the mevalonate pathway is initiated by condensation of two molecules of 
acetyl-CoA by function of acetoacetyl-CoA thiolase (Erg10). Then, through 5 enzymatic reactions the 
final product, IPP is produced, which is isomerized to DMAPP by Idi1. The pathway has been targeted 
in several investigations aiming at heterologous production of different isoprenoids (Ro et al., 2006; 
Asadollahi et al., 2009; Westfall et al., 2011). In order to increase the isoprenoid production in yeast, 
the pathway flux is modulated by focusing on increasing the local concentration of pathway enzymes 
and intermediates through employing different strategies altering the transcriptional level of bottleneck 
steps, for example, over-expression of 3-hydroxy-3-methylglutaryl-CoA reductase (Hmg1) and down-
regulating squalene synthase (Erg9) (Ro et al., 2006; Asadollahi et al., 2008; Asadollahi et al., 2009) 
However, in a recent investigation, 10 fold enhancement in amorpha-4,11-diene production was 
achieved by over-expressing every enzyme of the mevalonate pathway to ERG20 using a strong 
promoter (Westfall et al., 2011). Furthermore, the combination of these modifications, with 
improvement of the fermentation process, led to producing more than 40 g L
-1
 amorpha-4,11-diene 
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(Westfall et al., 2011). In a different approach, Asadollahi and co-workers tried to increase the 
sesquiterpene production by addressing targets that are neither involved directly in the pathway nor in 
supplying the precursor (Asadollahi et al., 2009). Following the result of in silico analysis, 
enhancement of the sesquitrepene was achieved through increasing the pool of NADPH which is 
consumed by the MVA pathway enzymes (Asadollahi et al., 2009). 
Further improvement of pathway yields has been achieved by employing different approaches, such as 
direct protein fusion and subcellular compartmentalization. In several studies, protein fusion strategies 
have been employed to redirect flux from the native MVA pathway downstream of the FPP branch 
point into the heterologous branch, leading to higher production of isoprenoids (Tokuhiro et al., 2009; 
Ohto et al., 2010; Albertsen et al., 2011). In all of these examples, the farnesyl pyrophosphate synthase 
(Erg20) was subjected to fusion with synthase enzymes like patchoulol synthase (PTS) or 
geranylgeranyl diphosphate synthase (Bts1). Tokuhiro and co-workers (2009) demonstrated 
enhancement of geranylgeranyl diphosphate (GGPP) production by 8-fold while utilizing fused Bts1-
Erg20, in comparison to individual expression of Bst1 and Erg20 (Tokuhiro et al., 2009).  
Organelle targeting has advantages in providing important cofactors and natural scaffolding or 
sequestering toxic compounds. Therefore, targeting the specific protein into the specific organelle 
within the cell is another approach to enhance biosynthetic pathway flux. Farhi and co-workers (2011) 
have used the mitochondrial targeting signal to localize the plant isoprenoid synthases, TPS1 and ADS 
in yeast mitochondria. They have also localized the endogenous FPP synthase (Erg20) to mitochondria 
using the targeting sequences from the COX4 gene fused to the N-terminus of TPS1, ADS and Erg20, 
individually (Farhi et al., 2011). They have demonstrated 3- and 20-fold increases in valencene and 
amorpha-4, 11-diene, respectively.  
 
1.4.2. 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway 
The MEP pathway was first reported independently by Rohmer and Arigoni (Rohmer et al., 1993; 
Arigoni et al., 1997). As illustrated in Figure 6, this pathway initiates by condensation of one molecule 
each of pyruvate and D-glyceralaldehyde-3-phosphate through a thiamin diphosphate dependent 
reaction catalyzed by 1-deoxy-D-xylulose 5-phosphate synthase (Dxs), (Sprenger et al., 1997), 
followed by the NADPH dependent reduction process being catalyzed by 1-deoxy-D-xylulose 5-
phosphate reductoisomerase (Dxr) (Takahashi et al., 1998), generating 2-C-methyl-D-erythritol 
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Figure 6: The MEP pathway (left). Enzymes: Dxs, 1-deoxy-D-xylulose-5-phosphate synthase; Dxr, 1-deoxy-D-
xylulose 5-phosphate reductoisomerase; IspD, 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase; IspE, 4-
diphosphocytidyl-2-C-methylerythritol kinase; IspF, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; 
IspG, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase; IspH, 1-hydroxy-2-methyl-butenyl 4-diphosphate 
reductase; Metabolites: 1, D-glyceraldehyde 3-phosphate;  2, pyruvate; 3, 1-deoxy-D-xylulose 5-phosphate; 4, 2-
C-methyl-D-erythritol 4-phosphate; 5, 4-diphosphocytidyl-2-C-methyl-D-erythritol; 6, 2-phospho-4-
diphosphocytidyl-2-C-methyl-D-erythritol; 7, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate; 8, 1-hydroxy-2-
methyl-2-(E)-butenyl 4-diphosphate. 
The MVA pathway (right). Enzymes: Erg10, acetoacetyl-CoA thiolase; Erg13, 3-hydroxy-3-methylglutaryl-
CoA synthase; Hmg1/2, 3-hydroxy-3-methylglutaryl-CoA reductase; Erg12, mevalonate kinase; Erg8, 
phosphomevalonate kinase; Erg19, mevalonate pyrophosphate decarboxylase; Idi, isopentenyl diphosphate 
isomerase; Metabolites: 9, acetyl-CoA; 10, acetoacetyl-CoA; 11, 3-hydroxy-3-methylglutaryl-CoA; 12, 
mevalonate; 13, phosphomevalonate; 14, diphosphomevalonate; 15, dimethyl allyl diphosphate; 16, isopentenyl 
diphosphate.  
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4-phosphate (MEP). This intermediate is converted into the cyclic 2,4-diphosphate of 2-C-methyl-D-
erythritol by the sequential action of the enzymes specified by IspD, IspE and IspF (Rohdich et al., 
1999; Lüttgen et al., 2000; Herz et al., 2000) 2-C-methyl-D-erythritol-2,4-cyclodiphosphate is reduced 
by a reductase encoded by the ispG gene (Adam et al., 2002; Querol et al., 2002) followed by the 
production of IPP and DMAPP by the action of the ispH gene product. (Rohdich et al., 2003; Wolff, 
2003).  
Similar to the MVA pathway in yeast, the MEP pathway has been subjected to metabolic engineering 
in E. coli in order to produce different isoprenoid compounds (Huang et al., 2001; Yuan et al., 2006; 
Kim & Keasling, 2001; Farmer & Liao 2001). The enhancement in accumulation of taxadiene, which 
is an intermediate of anticancer drug paclitaxel has been achieved through the over-expression of the 
first enzyme of the MEP pathway (Huang et al., 2001). Over-expression of both dxs and dxr led to 
increased lycopene production in E. coli (Kim & Keasling, 2001). The authors suggested that, like 
Dxs, the second enzyme of the MEP pathway has also an appreciable control coefficient over the flux 
(Kim & Keasling, 2001). Later, replacing the native promoter of dxr with the strong and constitutive 
promoter T5 from bacteriophage resulted in increasing production of β-carotene by more than 3 fold 
(Yuan et al., 2006). Farmer and Liao (2001) attempted to increase the availability of MEP pathway 
precursors pyruvate and glyceraldehyde 3-phosphate (G3P) in order to increase the pathway flux 
(Farmer & Liao 2001). Although strong competition exists for these substrates which are central 
metabolites involved in several pathways, such as the tricarboxylic acid cycle, glycolysis and 
gluconeogenesis and the pentose phosphate pathway, they have shown that lycopene accumulation is 
controlled by the G3P/pyruvate ratio and not by substrate availability (Farmer & Liao 2001). 
In general, all efforts in both S. cerevisiae and E. coli aimed at increasing isoprenoid production can be 
divided into two different approaches. In the first approach researchers tried to re-optimizae and 
regulate of the metabolic flux of the endogenous pathway, whereas, introduction of a heterologous 
pathway to supplement the native pathway was core of the second approach. To address the second 
one, the MVA pathway has successfully been transferred and optimized in heterologous hosts, e.g. E. 
coli (Martin et al., 2003; Dueber et al., 2009; Ma et al., 2011). However, few records have been found 
for investigating the MEP pathway in a heterologous host like S. cerevisiae (Maury et al., 2008). In the 
next chapter, both re-optimization of the endogenous MVA pathway and reconstruction of the 
bacterial MEP pathway in Saccharomyces cerevisiae will be considered through the usage of the new 
synthetic biology tools, also discussed in the next chapter. 
. 
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CHAPTER 2: RESULTS AND DISCUSSION 
 
High-level expression of exogenous or endogenous genes in microorganisms is often a desired 
objective with applications in protein production or to over-express pathway enzymes leading to 
synthesis of, e.g. chemicals or biofuels. Promoter choice and gene copy number are the most important 
factors to ensure the desired gene transcription levels. Regulation of gene dosage and gene 
transcription are the first two key steps in biological systems, e.g. allowing control of metabolic 
pathway function. Both plasmid and chromosomal integration are widely used as tools in this kind of 
modulation. Like in E. coli, different plasmids with varying features have been developed in yeast, 
while there are not as many different plasmids available as for E. coli. They have been employed for 
many metabolic engineering applications. Yeast episomal plasmids (YEp) usually offer high 
expression levels. Despite the fact that various YEp series have been developed (Table 1), their 
structure consists of two parts. The expression cassette includes promoter, multi cloning site (MCS) 
and terminator, and the maintenance section usually consists of two selection markers allowing 
selection in E. coli and yeast, respectively, and also bacterial origin of replication and 2µ sequences 
providing the stable segregation in both E .coli and yeast, respectively. Based on these facts, I 
proposed to construct a new series of 2µ episomal plasmids which can provide, not only high constant 
gene expression, but also can improve gene copy number using synthetic biology tools. 
The commercially available and widely used plasmid, pESC-URA (Stratagene, La Jolla, CA, USA), 
was chosen as a vector back-bone for our purposes. pESC-URA harbors the divergent and inducible 
GAL1-GAL10 promoter on the expression cassette providing strong protein expression in presence of 
galactose as carbon source. The maintenance section of this vector consists of the pUC origin and 
ampicillin resistance (ble) ORF, which both are necessary for maintenance in E. coli; whereas, 2 
micron and f1 origins in addition to the yeast URA3 ORF are used to replicate and maintain the vector 
in yeast culture, respectively.  
Thus, my experiments were designed to improve gene expression and gene dosage through modulating 
the elements involved in expression and maintenance sections of pESC-URA, respectively. In this 
chapter, first I review the final results leading to construct new expression plasmids and further I show 
the application of these new synthetic biology tools in optimizing the endogenous MVA pathway and 
in transferring the heterologous MEP pathway into S. cerevisiae. Finally, the role of the iron-sulfur 
cluster maturation process in the functionality of the MEP pathway will be discussed.      
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2.1. Regulation of expression level via promoter choice  
In spite of many advantages offered by employing the bidirectional plasmid pESC-URA, e.g. allowing 
high expression level and evaluation of two ORFs simultaneously, the galactose- dependent of the 
divergent GAL1/GAL10 promoter highlights the major disadvantage of pESC-URA in terms of time 
and economy, especially when aiming at industrial applications. Because, like most other organisms, 
S. cerevisiae has evolved to preferentially utilize fermentation carbohydrates, typically glucose, as 
carbon and energy sources (Ronne, 1995). Using glucose as a carbon source not only has economical 
benefits, this carbon source is 10 times cheaper in bulk as compared to galactose, but it is also possible 
to produce biomass faster and in higher amounts using glucose as compared to galactose. I initiated 
this study aiming at developing a glucose based system analogous to the GAL1/GAL10 system of the 
pESC vectors.  
Several strong constitutive promoters have previously been described and have been shown to be 
useful for expression of heterologous genes in yeast. In this study, the strength of seven different 
constitutive or glucose based promoters derived from the following genes - TEF1 (encoding 
transcriptional elongation factor EF-1 α) (Cottrelle et al., 1985), PGK1 (encoding phosphoglycerate 
kinase) (Ogden et al., 1986; Holland and Holland Biochemistry 1978) TPI1 (encoding triose 
phosphate isomerase), HXT7 (encoding a hexose transporter) (Diderich et al., 1999; Reifenberger et 
al., 1997), PYK1 (encoding pyruvate kinase 1) (Nishizawa et al., 1989), ADH1 (encoding alcohol 
dehydrogenase 1)(Denis et al.,1983) and TDH3 (GPD) (encoding triose phosphate dehydrogenase) 
(Bitter et al., 1984) have been compared in different stages of batch culture.  
 
2.1.1. Comparison based on β-galactosidase activity  
For this comparison, I used lacZ as a reporter gene and constructed 9 different integrative plasmids, in 
which lacZ expression was controlled by either of these promoters. In all cases, the constructed 
plasmids were integrated into the ura3-52 locus. Although, in the last decade, different reporter 
systems have been developed and used for promoter analysis in S. cerevisiae, such as green 
fluorescent protein (Li et al., 2000; Niedenthal et al.,1996), β-lactamase (Cartwright et al., 1994b) and 
β-D-glucuronidase (Nacken et al., 1996), β-galactosidase encoded by the lacZ gene of E. coli, is the 
most commonly employed reporter of gene expression in S. cerevisiae and is widely used for different 
purposes (Flick & Johnston, 1990; Hacker & Magdolen, 1992; Yocum et al.,1998). It was shown that 
lacZ, as a reporter, is not compatible with a high copy number vector, but suitable for expression 
monitoring in mono copy (Purvis et al., 1987). As I only wanted to compare the strength of different 
promoters and avoid gene copy number variations, I used lacZ on an integrative plasmid pSF01, a 
derivative of pRS306 (Sikorski & Hieter, 1989), for this comparison. The expression of lacZ 
20  RESULTS AND DISCUSSION  
controlled by these promoters was assayed 8, 24 and 48 hours after inoculation in shake flasks with 
2% glucose. The results are shown in Table 2.1. Since the TEF1 promoter is one of the strongest 
constitutive promoters (Gatignol et al., 1990) and since it showed the most stable and highest activity 
at different time points, I chose to set the PTEF1 activity at 8 hours as 100% and compared the activity 
of the other promoters relative to PTEF1 activity at this time point.  
Five of these promoters (PPGK1, PTPI1, PPYK1, PTDH3 and PADH1) operate the key glycolytic genes and they 
are generally considered constitutive and strong promoters, in the literature. They did not show a 
constant activity during the cultivation condition. Therefore, the classification of “constitutive” 
promoters is often wrongly associated with a “constant” expression rate of the controlled genes. In 
fact, the expression of the majority of genes is a function of the specific growth rate (Regenberg et al., 
2006), nutrition supplementation (Seresht et al., 2011) and environmental condition under which the 
cells are being cultured, e.g. oxygenation or temperature (Tai et al., 2007).     
Table 2.1: Comparison of the promoters used in batch cultivation with 2% glucose. 
 
The activities were normalized by setting PTEF1 activity at 8 hours to 100%. (Partow et al., 2010) 
In conclusion, I observed that the promoter activity varied with the glucose concentration and whether 
the cells were growing on glucose or ethanol. Taken together, the promoter activities, with the 
exception of PHXT7, decreased during shake flask cultivation. The overall ranking of the promoters is as 
described below: 
When cells are in exponential phase:  
PTEF1 ~ PPGK1 ~ PTDH3 > PTPI1 ~ PPYK1 > PADH1 > PHXT7 
When glucose is exhausted and ethanol is consumed: 
PTEF1 ~ PHXT7 > PPGK1 > PTPI1 ~ PTDH3 > PPYK1 ~ PADH1 
 
Since the aim of this investigation was to construct a dual glucose based expression system to replace 
the GAL1/GAL10 promoters in pESC-URA, I needed two promoters with a similar expression profile. 
As the results of the first comparison (Table 2.1), the PGK1 and TDH3 promoters represent options for 
a promoter that can be combined with PTEF1. Although both of them start with the same activity as 
PTEF1 after 8 hours, their activities decline. After 24 hours, this loss of activity for the TDH3 promoter 
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is higher than for the PGK1 promoter. Previous investigations by Mellor et al. (Mellor et al., 1985) 
showed that when the PGK1 gene was cloned into a multicopy plasmid and expressed in yeast, Pgk1p 
accumulated to up to approximately 50% of total cell protein. Furthermore, different powerful 
expression vectors were constructed, based on the promoter region of the PGK1 gene and these 
vectors have been used to study the expression of a number of heterologous genes (Tuite et al., 1982; 
Derynck et al., 1983; Masuda et al., 1994). I therefore chose the TEF1 and PGK1 promoters and, 
thereby constructed a nucleotide sequence containing a bidirectional TEF1-PGK1 promoter. 
 
2.1.2. Comparison of PTEF1 and PPGK1 in different contexts 
Since the fusion may effect on the individual promoter strength, the activity of PTEF1 and PPGK1 in the 
newly bidirectional promoter was compared with the activity of individual PTEF1 and PPGK1, 
respectively, in shake flasks using the same conditions as previously described, in which bidirectional 
TEF1-PGK1 promotes were cloned in front of lacZ in different orientation and then each construct 
was integrated into the ura3-52 locus. The results show that the activity of both the PGK1 promoter 
and TEF1 promoter after fusion to TEF1 and PGK1, respectively, are not significantly different when 
compared with those of PPGK1 and PTEF1 alone (Figs. 7A and 7B).   
 
Figure 7: Activity of PPGK1 and PTEF1 in different contexts; A, red columns represents the activity of individual 
PPGK1, gray columns represents the activity of PPGK1 fused to PTEF1; B, brown columns represent the activity of 
individual PTEF1, gray columns represents the activity of PTEF1 fused to PPGK1. Error bars represent SEM (standard 
error of measurement). 
 
Finally, the new divergent promoter, TEF1-PGK1, was employed as the basis for construction of 2 
different expression vectors, pSP-G1 and pSP-G2 (Figures 8A and 8B), which are useful for 
evaluating and expressing 2 different genes at the same time. The two different promoter orientations 
in pSP-G1 and pSP-G2 allow for a greater variety of cloning strategies due to the different promoter – 
multi cloning site (MCS) combinations. Later, by adding extra cloning sites at the end of each 
terminator (CYC1 and ADH1 terminator) in these plasmids, two further vectors were constructed, pSP-
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GM1 and pSP-GM2 (Figure 8C and 8D). these offer the opportunity to clone additional features, e.g. 
further expression cassettes. 
 
Figure 8: Schematic of pSP series. Details are presented in the text. 
 
2.2. Improvement of gene dosage via modulating the plasmid copy number  
Plasmid copy numbers of yeast episomal plasmids (YEps) usually are maintained by employing either 
the entire  S. cerevisiae native 2µ sequence or commonly, a 2µ sequence including both the origin and 
the stability locus (STB), REB3 (Futcher & Cox, 1983; Kikuchi, 1983). However, enhancing plasmid 
copy number, via modulating the selection marker gene, has been demonstrated by employing 
defective promoters as for the LEU2-d and URA3-d allels leading to poorly express selection marker 
genes (Beggs, 1978; Erhartt & Hollenberg, 1983; Loision et al., 1989). It was shown that poor 
expression of the selection marker is a driving force to increase the plasmid copy number to ensure 
cell survival (Beggs, 1978)(Erhart & Hollenberg, 1983; Loision et al., 1989). Another possible 
approach for improving the dosage of the gene on the recombinant plasmid is destabilization of the 
marker at the protein level using protein-based control elements. These elements act through protein 
degradation and, usually, alter the protein half-lives (Mateus & Avery, 2000; Hackett et al., 2006; 
Grilly et al., 2007). We hypothesize that the destabilization of marker protein may indicate the same 
effect as poorly expressed marker gene on the plasmid copy number.  
I examined two strategies individually and in combination, in order to reduce the maker gene at both 
protein and RNA levels, and their impact on plasmid copy number of pSP-GM1 (Figure 8C). First, a 
ubiquitin/N-degron tag was fused to the N-terminus of Ura3 (selection marker of pSP-GM1). The S. 
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cerevisiae N-degron signal sequence can lead to impressive destabilization of reporters down to a half-
life of 2 min (Hackett et al., 2006). Second, down-regulation of the marker gene URA3 at the 
transcriptional level was altered by replacing the URA3 native promoter with the constitutive weak 
promoter KEX2 (Fuller et al., 1989), the conditional promoter of HXT1 encoding a low affinity hexose 
transporter (Diderich et al., 1999) and the promoter of the URA3-d allele including only 47 nucleotides 
located upstream of the start codon (Faulkner et al., 1994; Loision et al., 1989), respectively. Further, I 
combined both stategies, i.e. weak promoter and ubiquitin/N-degron tag and evaluated plasmid copy 
number in these conditions. Figure 9 illustratesthe plasmid constructs.   
 
Figure 9: Schematic representation of the plasmid constructs. PURA3, PHXT1, PKEX2, and PURA3-d, promoters 
employed to control URA3 expression; Ubi-R, Ubi-M, Ubi-E and Ubi-Q, ubiquitin/N-degron tags leading to 
arginine, methionine, glutamate and glutamine as N-terminal residues of the Ura3 marker protein. 
 
2.2.1. Plasmid copy number determination via LacZ enzyme assay and quantitative PCR in 
continuous culture 
Novel culture strategies have been developed, which allowed the physiological characterization of 
cells under regulated and defined conditions, aiming at reproducible processes and conclusive 
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experimental designs. The invention of chemostat cultivations is one of such tools, and its first 
application goes back to the 1950s (Novic & Szilard, 1950). The unique feature of chemostat 
cultivation is the ability to grow a cell population under well-defined substrate-limited growth 
conditions for an indefinite duration. Hence, applying the same growth condition for different 
engineered strain in continuous culture would raise the potential of this cultivation systems usage for 
many biotechnological investigations, e.g. plasmid copy number. An aerobic glucose-limited 
continuous cultivation of S. cerevisiae at a fixed dilution rate below the maximum specific growth rate 
was performed in our experiments. Apart from strain SCISP23 (Table 2.2) carrying the the PHXT1-
URA3 plasmid indicating a lower final biomass formation, no apparent difference in growth 
characteristics and morphology was observed for the other strains. The observed decrease in biomass 
production may be the results of the high repression level of URA3 exerted by the HXT1 promoter 
under glucose limitation, not providing sufficient Ura3 protein to maintain higher growth rates or to 
elevate the dilution rate. This is consistent with the results observed in auxotrophic yeast strains during 
uracil-limited chemostat culture (Olitta et al., 2010).     
Altering the plasmid copy number was verified after applying the above mentioned modifications on 
plasmid structure (see section 2.3) by two different methods, LacZ enzyme assay and quantitative 
PCR. The results of these indirect and direct measurements are demonstrated in Table 2.2.  
Table 2.2: Comparison of fold changes in LacZ activity and plasmid copy number (PCN) 
 
The results showed that both the LacZ activity and the plasmid copy number can be further increased 
by combining (i) destabilization of the marker protein, and (ii) replacing the promoter of the marker 
gene with a weak promoter. However, fold changes revealed by the Ubi-tagged (Ubi-M, Ubi-E and 
Ubi-Q) strains are not really significant and less than 50%. Both LacZ and PCN measurements are 
comparable and show high correlation with little exception such as SCIYC68 showing different fold 
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change between LacZ activity and plasmid copy number (PCN). Combination of the weak promoter 
and ubiquitin tag showed a synergistic effect on plasmid copy number and LacZ activity. This 
synergistic effect induced by the PKEX2-Ubi-R was more stable in comparison to what was observed for 
the PHXT1-Ubi-R. SCYC68 displayed higher increase in plasmid copy number than increase of LacZ 
activity (Table 3). This could, conceivably, relate to the feature of the HXT1 promoter, in addition to 
the destabilizing residue arginine, resulting in very low expression of URA3 and, thereby, more 
pressure on the cells.  
 
2.2.2. Impact of plasmid copy number on patchoulol production  
Patchouli is a type of sesquiterpene obtained by steam distillation of the leaves of Pogostemon cablin 
(patchouli), a plant from the Lamiaceae family. This terpenoid derivative is an important ingredient in 
many fine fragrance products like perfumes, as well as in soaps and cosmetic products. Microbial 
production of this fragrance compound is of great interest in the perfume industry, as an alternative to 
extraction from plants. Like other sesquiterpenes, patchoulol is derived from farnesyl diphosphate 
(FPP), which is an intermediate of the sterol pathway (Figure 10A). The patchouli synthase gene has 
been isolated before (Munck & Croteau, 1990) and it has been shown that to convert FPP into 
patchoulol, only a single enzymatic step is sufficient (Asadollahi et al., 2008). To demonstrate the 
practical application of this new plasmid, the plasmid carrying the PKEX2-Ubi-R-URA3 construct was 
tested for production of the isoprenoid patchoulol. To ensure that enough FPP precursors are available, 
a truncated form of HMG-CoA reductase 1 (encoded by tHMG1) was also over-expressed from this 
plasmid. tHMG1 overexpression has previously been reported to lead to enhanced isoprenoid 
production in yeast (Ro et al., 2006; Asadollahi et al., 2010). Both tHMG1 and the patchoulol synthase 
gene (PatTps177) were expressed from the PKEX2-Ubi-R-URA3 plasmid(strain SCIYC76) as well as 
from the control plasmid (strain SCIYC72) (figure 10B). Patchoulol production and biomass 
formation were analysed in shake flasks (Figure 10C). While the final biomass concentration was 
unchanged, patchoulol production reached about 30 mg/L in SCIYC76, more than 3 times compared 
with control strain SCIYC72. This performance thus demonstrates that the new plasmid could also be 
beneficial to improve heterologous pathway expression. 
 
26  RESULTS AND DISCUSSION  
 
Figure 10: Growth and patchoulol accumulation of strain SCIYC76 and control strain SCIYC72. A, mevalonate 
pathway, red arrows correspond to the over-expressed genes; B, map of modified expression plasmid, pIYC49 
(PKEX2-Ubi-R-URA3) which harbors a copy of tHMG1 and PatPs177 genes downstream of the TEF1 and PGK1 
promoter, respectively; C, Patchoulol production was evaluated in shake flasks using 2% glucose minimal 
medium. SCIYC76 contains plasmid pIYC49 (PKEX2-Ubi-R-URA3) and control strain SCIYC72 contains plasmid 
pIYC03 (PURA3-URA3). The data shown represent the mean +/- SD of three independent cultivations.  
   
2.3. Implementation of synthetic biology tools in metabolic engineering 
The goal of metabolic engineering is to optimize and modulate processes within cells by directed 
modifications of metabolic fluxes employing synthetic biology tools. Many of the described synthetic 
biology tools and techniques in Chapter 1 have already been applied to engineer yeast strain for 
production of valuable secondary metabolites, e.g. isoprenoids, in novel and efficient bioprocess that 
are environmentally friendly. Briefly, altering one or many of the following levels can be subjected in 
order to over-produce secondary metabolites through interruptions to cellular metabolism: (i) 
enhancement in the rate of substrate uptake, (ii) reduction of flux to undesirable by-products and 
enhancement of precursor and cofactor flux, (iii) introduction of a heterologous pathway and 
optimization of the activity of its constituent enzymes, and (iv) export of the product to the 
extracellular medium in order to shift the equilibrium towards product formation. In this principle, first 
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the application of various synthetic biology tools and techniques for metabolic engineering of the 
mevalonate pathway aiming at producing a sesquiterpenoid, α-santalene, are discussed and, 
furthermore, the last results of the re-construction of the bacterial MEP pathway and sophisticated 
challenges in cytosolic Fe/S cluster trafficking to the last two enzymes of this heterologous pathway in 
S. cerevisiae will be considered. 
 
2.4. Metabolic engineering of the MVA pathway 
The MVA pathway in yeast endogenously synthesizes different natural isoprenoids compounds which 
are responsible to control key functions in the cell, e.g. membrane fluidity (ergosterol) and mating 
response (a-factor). Therefore, yeast is naturally and potentially able to supply many precursors and 
intermediates which are needed for producing various heterologous isoprenoids, e.g. sesquiterpenoids 
(Ro et al., 2006; Asadollahi et al., 2008; Asadollahi et al., 2009; Asadollahi et al., 2010). 
Sesquiterpenoids are a type of isoprenoids produced by the cyclization and further modification of a 
single farnesyl diphosphate (FPP) intermediate, a branch point of the MVA pathway. α-Santalene, 
which is the precursor of α-santalol, one of the main components of East Indian sandalwood oil 
(Baldovini & Joulain, 2011), is a type of sesqiterpene with application in perfumery and aromatherapy 
industries. Like patchoulol, α-santalene is produced enzymatically in a one-step-conversion from 
farnesol diphosphate catalyzed by a plant santalene synthase (Schalk, 2011). Here, Re-optimization of 
the MVA pathway is investigated using synthetic biology tools aiming at enhancing the FPP pool for 
production of α-santalene. First, different and novel approaches are applied for modulating the FPP 
branch point. Second, the possible nodes which have direct influence on the MVA pathway flux or 
necessary co-factor are manipulated and finally, an efficient S. cerevisiae strain capable of reaching 
relevant titers and productivities of α-santalene during an optimized fermentation process is 
constructed combining all modifications. 
 
2.4.1. Modulating the FPP branch point  
Farnesyl diphosphate (FPP) is the universal precursor unit of all sesquiterpenes (C15) (Maury et al., 
2005)(Withers & Keasling, 2007). This intermediate is formed by multiple condensations of 
isopentenyl-diphosphate (IPP) and dimethyllallyl diphosphate (DMAPP) and, naturally, it serves as a 
precursor for production of essential compounds such as dolichol, ubiquinone, isoprenylated proteins 
and ergosterol (Daum et al., 1998) (Figure 11). Therefore, the FPP intracellular concentration is 
tightly regulated at different levels (Goldstein & Brown, 1990). During normal growth conditions 
most of the FPP is used for sterol biosynthesis, due to the fact that the cellular demand for sterols is 
greater compared to the demand for non-sterol FPP derived compounds (Kennedy et al., 1999). 
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Figure 11: Schematic representation of the farnesyl pyrophosphate (FPP) branch-point in S. cerevisiae; A, 
Cytosol; B, Mitochondria; C, Lipid particle; D, Endoplasmic reticulum.  
 
Squalene synthase (Erg9) is the first enzyme of the mevalonate pathway dedicated to sterol 
biosynthesis. Since disruption of the ERG9 gene is lethal and produces an ergosterol-dependent mutant 
(Jennings et al., 1991), several efforts have applied various methods down-regulating this essential 
genes, in order to increase the FPP pool (Ro et al., 2006; Paradise et al., 2008; Asadollahi et al., 2008). 
Generally, researchers have replaced the native ERG9 promoter with the regulatable promoter MET3, 
which is repressed in the presence of methionine (Cherest et al., 1985). However, applying the 
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regulatable-promoter MET3 is limited by several parameters such as the cost of methionine for 
repression and difficulty with controlling the system since the repressing agent, methionine is 
metabolized by the cells. So, we first hypothesized that the repression effect on the MET3 promoter 
may reduce over time. To verify this hypothesis, an integration cassette containing lacZ as a reporter 
downstream of the MET3 promoter was constructed (Figure 12A). The LacZ activity was measured at 
different time points after addition of 0 mM, 1 mM and 2 mM L-methionine, respectively. The results 
showed that LacZ activity was increased, about mid-exponential, after methionine addition and rapidly 
reached the levels measured in the non-repressed culture (Figure 12B). These results, thus, 
demonstrate and confirm the difficulties in controlling promoter activity when cells metabolize the 
repressing agent.  
In the following, down-regulation of ERG9 was evaluated using two synthetic biology tools, promoter 
choice and antisense mRNA. The chosen regulatory systems were (i) the low-level constitutive TEF1 
promoter mutant TEF1M2 selected after an evolutionary engineering approach based on error-prone 
PCR (Alper et al., 2005; Nevoigt et al., 2007), (ii) the glucose concentration controlled promoter of the 
hexose transporter gene HXT1 (Ozcan& Johnston, 1995; Lewis & Bisson, 1991), and (iii) the HXT2 
promoter potentially useful for a gene silencing approach expressing ERG9 antisense mRNA (Ozcan 
et al., 1995). These promoters were cloned and integrated in front of lacZ and integrated into the yeast 
chromosome, respectively (Figure 12A), and their effect was compared during high and low glucose 
concentration  using lacZ, as a reporter (Figures 12C and 12D). Further, the impact of different 
down-regulating methods on ergosterol and α-santalene production was evaluated in a fed-batch 
process (Figures 12E and 12F). Taken together, the results indicate that (i) PHXT1 appeared to be a 
suitable promoter for down-regulating ERG9 expression under glucose limiting conditions; (ii) The 
proportion of ergosterol decrease ranged from 50 to 91% using the above mentioned methods (Figure 
12E) as compared to the native ERG9 promoter, and (iii) a linear correlation was observed between 
the reduction in ergosterol content and the increase in α-santalene production. This is a good example 
of using synthetic biology in metabolic engineering showing the redirection of FPP flux through 
sesquiterpen production by replacing the native ERG9 promoter with conditional promoter HXT1. 
Besides, additional modifications for modulating the FPP branch point have been investigated, e.g. 
deletion of two phosphatases LPP1 and DPP1, which are responsible for most of the cytosolic 
isoprenoid and lipid phosphate phosphatase activity in S. cerevisiae (Toke et al., 1998; Faulkner et al., 
1999). However, no significant differences were observed in both α-santalene production and 
ergosterol content applying single deletion (lpp1∆) or double deletion (lpp1∆ dpp1∆) strains. 
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Figure 12: Result of the regulation of FPP branch point. (A) Integrative cassettes include promoter choice 
(MET3, HXT1, HXT2 and mutant TEF1) in front of lacZ as a reporter gene; (B) LacZ activity under control of 
PMET3 in response to different methionine concentrations, 0 mM (diamonds), 1 mM (triangles) and 2 mM 
(circles). Strains were cultivated in duplicates, glucose exponential growth phase was between 2 and 16 h of 
cultivation; (C and D) Characterization of promoter strength, PHXT1 (filled diamonds), PTEF1M2 (filled circles), 
PHXT2 (empty squares), and PERG9 (filled squares), during shake flask cultivation in glucose exponential growth 
phase was between 2 and 16 h of cultivation and in fed-batch mode, respectively. (E) Ergosterol production rate 
(mg*g biomass
-1•h-1); (F) α-santalene and E,E-farnesol prodcution rate (mg•g biomass-1•h-1), Strains were grown 
in a two-phase partitioned fed-batch glucose limited cultivation mode. The error bars represent the standard 
deviation for two independent cultivations. 
RESULTS AND DISCUSSION   31 
2.4.2. Modulating the possible nodes directly involved or related to the MVA pathway  
Manipulating a single gene pathway usually has little effect on metabolite fluxes as individual 
enzymes generally have only partial flux control in a pathway. Therefore, further improvement of 
sesquiterpene production was investigated by manipulating several direct and indirect rate-limiting 
steps of the FPP biosynthesis pathway (early portion of MVA pathway) which is illustrated in 
Figure13A.  
The MVA pathway initiates by condensation of 3 acetyl-CoA molecules to build one molecule of 
mevalonate which is through sequential phosphorylation and decarboxylation enzymatic steps, forms 
IPP and DMAPP. The final step in the early portion of the MVA pathway is the conversion of IPP and 
DMAPP into geranyl and farnesyl diphosphates (GPP and FPP, respectively). These steps are 
catalyzed by the product of ERG20 (Maury et al., 2005). The enzyme first combines one molecule of 
each DMAPP and IPP to make GPP and then by adding one molecule of IPP to GPP produces FPP. 
Several enzymatic steps and co-factor requirments make the regulation of the mevalonate pathway 
complex. A reductase (HMG-R), encoded by HMG1 is a highly regulated enzyme and it is considered 
to represent the major rate limiting enzyme in the MVA pathway (Basson et al., 1987; Donald et al., 
1997; Polakowski & Stahl, 1998).  
Several studies have demonstrated an enhancement in isoprenoid production by over-expression of the 
catalytic domain of the Hmg1 protein encoded by tHMG1 (Ro et al., 2006; Kirby et al., 2008; Engels 
et al., 2008; Asadollahi et al., 2010). Over-expression of ERG20 exposed a slight effect on 
sesquiterpene production (Ro et al., 2006). Further manipulation has been performed by over-
expression of a semi-dominant mutant allele of a global transcription factor regulating sterol 
biosynthesis in yeast, upc2-1, that enhances the activity of Upc2 (Davies et al., 2005) and the impact 
of this over-expression on isoprenoid production has been demonstrated (Ro et al., 2006; Engels et al., 
2008). Enzymes of the MVA pathway are NADPH-dependent e.g. Hmg1 (Maury et al., 2005). Hence, 
the last modification was implemented in order to increase the pool of NADPH available for Hmg1. 
Previously, it has been reported that an there was an improvement in sesquiterpene production by 
manipulating the ammonium metabolism in yeast (Asadollahi et al., 2009). Deletion of the GDH1 
encoding NADP-dependent enzyme which consumes a substantial amount of NADPH in the cell (dos 
Santos et al., 2003) and over-expression of the NADH-dependent enzyme, GDH2, has led to an, 
approximately, 85% increase in the final cubebol titer (Asadollahi et al., 2009).  
The impact of the above mentioned modifications on isoprenoid production have previously been 
investigated individually. Here, different combinations of all these modifications were investigated 
using chromosomal integration to ensure the genetic stability of the host strain. Unique cloning sites 
after ADH1 and CYC1 terminators of pSP-GM1 allowed simple and efficient construction of the two 
integration cassettes (Figure 13B). The synthetic cassettes were further introduced into the yeast 
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chromosome through homologous recombination. Modified strains were engineered into a 
sesquitrepene producing microorganism introducing the expression plasmid pISP15 containing a copy 
of tHMG1 and codon optimized SanSyn under control of the PGK1 and TEF1 promoter, respectively. 
Name and descriptions of the strains are listed in Table 2.3. In the following, continuous cultures were 
employed to evaluate the impact of different genetic modifications on α-santalene production. Results 
are shown in Figure 14. 
 
Table 2.3: List of S. cerevisiae strains used in this study 
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Figure 13: Schematic representation of the engineered α-santalene biosynthetic pathway through the 
modification of the mevalonate pathway and the ammonium metabolism pathway in S. cerevisiae. A, The 
directly up-regulated genes are shown in red and purple; those that are indirectly up-regulated by upc2-1 
expression are in blue; the pathway intermediates IPP, DMAPP and GPP are defined as isopentenyl 
pyrophosphate, dimethyl allyl pyrophosphate and geranyl pyrophosphate, respectively. Green arrow indicates the 
enzymatic step leading from farnesyl pyrophosphate (FPP) to α-santalene. B, Maps of the integrative constructs 
used for transferring all modifications into the yeast chromosome and plasmid expression cassette carrying 
additional copy of tHMG1 and SanSyn.   
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We showed that the combination of ERG9 down-regulation and double lpp1/dpp1 deletion increased 
α-santalene production by more than 3 times as compared to the wild type strain (SCIGS28) (Figure 
12E). Further modifications were implemented on SCIGS30 as background strain (Table 2.3). 
Introducing GDH1 deletion into SCIGS30 not only showed a decrease in α-santalene production 
(Figure 14), but also strongly affected the growth rate which decreased to 0.18 h-1. The latter effect is 
consistent with what has been previously reported by Asadollahi and co-workers (Asadollahi et al., 
2009); however, they have shown improvement in sesquiterpene production using a gdh1 mutant. 
Both growth rate and α-santalene production were enhanced dramatically (stain SCIGS24) while a 
combination of ERG20/GDH2 overexpression was introduced into SCIGS31. This can be explained 
by the fact that deletion of GDH1 has high impact on the efficiency of ammonium assimilation under 
these conditions (dos Santos et al., 2003) and this undesirable effect is considerably avoided over-
expressing GDH2 (Asadollahi et al., 2009). Thus, enhancement of α-santalene production could result 
from growth restoration by over expression of GDH2 and over-expression of the gene encoding FPP 
synthase (ERG20). However, the later has shown little effect on total sesquiterpene, amorphiadiene, 
production (Ro et al., 2006). To combine all modifications, an additional copy of tHMG1 and a copy 
of upc2-1 were integrated into the chromosome of SCIGS25 resulting in SCIGS25, although 
combining all these modifications did not show further improvement in α-santalene production in 
comparison to SCIGS24 (Figure 14). This result is consistent with previous reports which have shown 
that, at high mevalonate concentrations (>2.5 mM) the reaction rate of S. cerevisiae mevalonate kinase 
(ERG12) begins to decrease (Ma et al., 2011). It has also been demonstrated that there is substrate 
inhibition of the mevalonate kinase of S. aureus at high concentrations of mevalonate (Voynova et al., 
2004).  
 
Figure 14: α-(+)-santalene production rate Cmmol (g Biomass)-1 h-1 in S. cerevisiae in a two phase partitioned 
glucose limited aerobic chemostat. Strains SCIGS28, SCIGS29 (PHXT1-ERG9; Δdpp1), SCIGS30 (+Δlpp1), 
SCIGS31 (+Δgdh1), SCIGS24 (+ERG20; GDH2), SCIGS25 (+upc2-1, tHMG1) cultivated at dilution rate 
D=0.05 h
-1
. 
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2.5. Re-construction of the bacterial MEP pathway in S. cerevisiae 
Due to the importance of isoprenoid compounds involved, not only in several metabolic functions, e.g. 
photosynthesis (chlorophylls), respiration (ubiquinone), hormonal regulation of metabolism (steroids), 
intracellular interaction (RAS proteins), but also their many industrial applications such as food 
colorants (carotenoids), pharmaceuticals (artemisinin, taxol, and bisabolol), flavors and fragrances 
(limonene), synthesis of isoprenoid compounds through the natural metabolic pathways, MVA or 
MEP pathway, has extensively been considered (Maury et al., 2005; Chang & Keasling, 2006). As 
aforementioned, by employing synthetic biology tools, such as strong bidirectional promoters and high 
copy number plasmids, we re-optimized the endogenous MVA pathway in S. cerevisiae in order to 
over-produce α-(+)-santalene. Instead of all these efforts, the bacterial MEP pathway could be a 
potential target for isoprenoid production, which has not been investigated extensively, in particular in 
heterologous hosts like S. cerevisiae. These findings encouraged me to further evaluate the 
heterologous MEP pathway in S. cerevisiae aiming at generating an efficient yeast cell factory with 
both the MVA and MEP pathway for producing isoprenoid precursors. 
 
2.5.1. In silico analysis of the bacterial MEP pathway 
In order to better understand the behavior of the MEP pathway in yeast, the seven enzymatic reactions 
of the bacterial MEP pathway were evaluated in silico, using the yeast genome scale metabolic model, 
iIN800 (Nookaew et al., 2008). The efficiency of the pathway was compared with the endogenous 
MVA pathway. The model was optimized for maximum production of farnesyl pyrophosphate (FPP), 
which is a branch point intermediate in ergosterol biosynthesis, for two different conditions, using the 
endogenous MVA pathway and using the heterologous MEP pathway, respectively. The result showed 
that by consuming 1 mol of glucose 0.21 and 0.24 mol farnesyl pyrophosphate could be produced 
through the MVA and MEP pathway, respectively. According to this analysis, the FPP production 
through the MEP pathway results in a favourable theoretical yield.  
The stoichiometry calculation of glucose, NAD(P)H and ATP consumption to produce one molecule 
of  FPP for both pathways shown in Equation 1.  
 
The stoichiometry showed that, for producing one molecule of farnesyl pyrophosphate from glucose 
via the MVA pathway six molecules of NADPH and nine molecules of ATP are required, while 
production via the MEP pathway consumes nine molecules of NAD(P)H and six molecules of ATP. 
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Provision of sufficient cytosolic NADPH is, therefore, a critical factor for both pathways. In contrast 
to the MEP pathway, which consumes only 3 molecules of glucose, the MVA pathway consumes 4.5 
molecules of glucose for the biosynthesis of one molecule farnesyl pyrophosphate (these values are 
excluding use of glucose for production of ATP and redox co-factors).  
Combining the results derived from the yeast genome scale metabolic model and the stoichiometry 
calculations, it became evident that the MEP pathway is a more efficient route than the endogenous 
MVA pathway for isoprenoid production in terms of energy consumption and productivity. This result 
is consistent with previous reports about the efficiency of the MEP pathway, as compared to the MVA 
pathway (Ajikumar et al., 2010; Dugar & Stephanopoulos, 2011). This is the rationale for my attempt 
to express the bacterial MEP pathway in yeast for production of isoprenoids. 
2.5.2. Genomic integration of MEP pathway genes 
For further evaluation, the four DNA constructs containing the MEP pathway genes, expression 
elements and selection markers were well designed in silico, synthesized in vitro (chemically) and 
integrated into the yeast chromosome applied by a bipartite integration strategy (Erdeniz et al.,1997), 
respectively. The strains generated in this study are listed in Table 2.4.  
Table 2.4: List of strains and plasmids used in evaluation MEP pathway study 
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The in vitro DNA synthesis offers fast, cheap and efficient method for synthesis of large DNA 
sequences (Kosuri et al., 2010; Matzas et al., 2010). Besides, using synthetic genes with the possibility 
to manipulate codon bias can take much better control of the expression of heterologous MEP pathway 
in yeast. From the genetic engineering point of view, the codon bias is one of the first barriers in 
heterologous protein expression (Gustafsson et al., 2004) and it can prevent the efficient biosynthesis 
of a recombinant protein, because of altering the correlation between the frequency of the codon and 
the abundance of its corresponding tRNA, which impairs the translation machinery of the host 
(Ikemura, 1981). The high efficiency and ease to work with in vivo homologous recombination in      
S. cerevisiae allows stable manipulation without requirement of selective pressure for maintenance. In 
addition, previously, different transcription levels among various chromosomal regions in S. cerevisiae 
have been reported by using lacZ as a reporter gene (Flagfeldt et al., 2009). We have shown that the 
two integration sites, YPRCΔ15 and YPRCτ3, on chromosome XVI of S. cerevisiae provided 
potentially higher expression levels than other regions tested (Flagfeldt et al., 2009). Therefore, all 
genes involved in the bacterial MEP pathway were integrated into these two sites in two steps. Figure 
15 illustrates synthetic constructs and integration methods in greater detail. As can be seen in this 
figure, the constitutive bidirectional promoter TEF1-PGK1 was used to support strong transcription 
level, as I showed high constitutive activity of this promoter in glucose containing media before. In 
addition, direct repeat DNA sequences of 143 bp introduced at both sides of K.l.URA3, and loxP sites 
flanking the kanMX cassette allowed recycling of the selectable markers.   
 
 
Figure 15: Schematic representation of genetic engineering strategies for genomic integration of the bacterial 
MEP pathway genes into the yeast genome (chromosome XVI). 
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In spite of successful integration and transcription, which were confirmed by PCR and RT-PCR, 
respectively, the bacterial MEP pathway could not complement the lack of endogenous MVA pathway 
while being repressed in presence of lovastatin, which is a therapeutic agent and is a competitive 
inhibitor of an early pathway enzyme, HMG-CoA reductase (Alberts et al., 1980) (Figure 16). This is 
in contrast to previously reported findings (Maury et al., 2008). Maury and co-workers reconstructed 
the bacterial MEP pathway in S. cerevisiae by expression of seven enzymatic steps of the pathway 
from self-replicating, high-copy yeast plasmids. They have reported the ability of the bacterial MEP 
pathway in producing ergosterol, which is essential compound in S. cerevisiae, while the endogenous 
MVA pathway was inhibited through addition of lovastatin (Maury et al., 2008). We conclude that 
their result may have derived from incomplete repression of the MVA pathway, even when higher 
concentrations (2 g L-1) of lovastatin were used, which may result from errors in activation of 
lovastatin by hydrolysis reducing the actual concentration of the active inhibitor, or the higher-level 
expression from multi-copy plasmids may have resulted in partial activation of the enzymes resulting 
in a functional MEP pathway. However, later genetic inhibition of MVA pathway revealed the non-
functionality of the MEP pathway to the same level as the chemically inhibited. A brief overview of 
the enzymatic steps shows that, in general, the MEP pathway requires divalent metal cations such as 
Mn
2+
, Mg
2+
 or Co
2+
, ATP for providing energy and a reducing agent, such as NADPH (Maury et al., 
2005). Providing such requirements should not be limiting for a legitimate activity of the pathway. 
Metabolite analysis was therefore performed to identify possible bottleneck(s) within the MEP 
pathway. The detection of intermediates 3 and 5 (Figure 6) in the MEP-pathway carrying yeast strains 
indicated the proper activity of the Dxs, Dxr and the IspD enzymes (data not shown). In addition, non-
activity was observed for the last enzyme of the MEP pathway, IspH, while expressed in yeast 
(Formenti, 2011). We hypothesize that a potential reason for the non-functionality of the MEP 
pathway in S. cerevisiae is the lack of the enzyme activity of IspG and/or IspH, which catalyze the last 
two reactions of the pathway. Both the IspG and IspH are known to be iron-sulfur cluster proteins 
(Adam et al., 2002;
 
Querol et al., 2002;
 
Rohdich et al., 2003;
 
Seemann et al., 2005; Altincicek et al., 
2002;
 
Gräwert et al., 2010) and it has been reported that the cluster is directly involved in IspH activity 
(Gräwert et al., 2004). Our hypothesis was supported with findings of the essential role of ErpA, 
which is an A-type iron-sulfur cluster protein, in the maturation process of IspG, and probably IspH, in 
E. coli.(Loiseau et al., 2007). So, focus turned to the reconstruction of the bacterial Fe-S cluster 
trafficking routes involved in maturation of IspG and IspH in S. cerevisiae. 
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Figure 16: Growth of Saccharomyces cerevisiae strains CEN.PK 113-13D (black circles) and SCISP06 (gray 
circles) in SD minimal medium. Dashed lines represent the growth in 0 g L
-1
 of lovastatin; solid lines represent 
the growth in presence of 2 g L
-1
 of lovastatin. Error bars show the standard deviation from three cultivations. 
 
2.6. Fe-S clusters protein biogenesis in E. coli and S. cerevisiae  
In terms of evolution, Fe-S clusters are thought to be one of the first catalysts in nature. The Fe/S 
clusters combined within protein structure play several vital functions in living cells, e.g. enzymatic 
reactions, ribosome biogenesis, regulation of gene expression, respiration, co-factor biosynthesis and 
so on. Therefore, understanding of the mechanisms leading to assembly of this small inorganic 
molecule not only is interesting, but it is also necessary to solve many disorders which are connected 
to defective Fe/S-cluster biogenesis, e.g. Friederich’s ataxia, sideroblastic anemia or hereditary 
myopathy (Campuzano et al., 1996; Camaschella et al., 2007 and Ye and Rouault 2010). The rhombic 
[2Fe-2S] and cubic [4Fe-4S] are the most common and simplest types of iron-sulfur clusters found in 
nature. However, the distorted [3Fe-4S] type may be found in several proteins. Unlike bacterial 
biogenesis, in eukaryotes e.g. yeast, Fe-S clusters biogenesis mainly is performed in mitochondria and 
this organelle plays a central role in maturation of Fe/S proteins (Lill & Mühlenhoff, 2008; Py & 
Barras, 2010). The mitochondrial biogenesis is also necessary for maturation of the Fe/S cluster 
proteins localized in the cytosol and nucleus, which in yeast also involves the cytosolic Fe/S protein 
assembly (CIA) machinery (Sharma et al., 2010).  
Instead of the compartmental localization, the major elements involved in iron-sulfur cluster 
biogenesis are linked through the evolution from bacteria to eukaryote (E. coli / Yeast) comprising a 
cysteine desulfurase supplying the sulfur (IscS and SufS /Nfs1and Isd11), an iron sensor/doner (CyaY 
/ Yfh1), electron donor (Fdx / Yah1 and Arh1) and a scaffold protein which forms a platform to 
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assemble both the rhombic and cubic types (IscU / Iscu1 and Iscu2). In fact, Fe-S clusters are the 
result of close interaction between scaffold protein with cysteine desulfurase and an iron donor. 
Finally, the clusters are transferred to the acceptor apo-protein by action of the series of chaperone-like 
protein (HscA and HscB / Ssq1, Jac1 and Mge1), which occurs in collaboration with the scaffold 
protein. The clusters can be transferred into the cytoplasm, probably by a mitochondrial ISC export 
apparatus (Atm1 and Erv1) and, furthermore, through the activity of CIA machinery which contains 
Nbp35, Cfd1, Nar1, Cia1 and Dre2, the clusters are transferred into cytosolic and nuclear apo-proteins 
(Figure 17). The latter two apparatuses, mitochondrial ISC export and CIA, are not found in bacteria. 
There are other elements which are involved in Fe-S clusters biogenesis. However, the function of 
most of them is not clearly identified, such as A-type proteins (IscA, SufA and ErpA in E.coli and Isa1 
and Isa2 in yeast mitochondria). The A-type carriers in bacteria can bind both types of Fe-S clusters 
and can transfer them to apo-proteins in vitro (Loiseau et al., 2007; Tan, Lu et al., 2009). Hence, the 
scaffold function was initially proposed for this type of proteins. However, their inability to interact 
with cysteine desulfurase rejects this proposed role. Later, it has been shown that Fe/S clusters can be 
transferred from IscU to IscA (Ollagnier de Choudens et al., 2004). Moreover, purified A-types 
proteins containing Fe-S clusters have been isolated (Gupta et al., 2009; Zeng et al., 2007). Thus, 
transferring the Fe/S clusters to apo-targets from a scaffold is a more likely function for the A-type 
proteins. Indicating the role of ErpA in transferring Fe-S cluster to IspG and probably IspH, was the 
first report showing a specific target, apo-protein, in vivo (Loiseau et al., 2007). And finally, Vinnela 
and co-workers (2009) proposed different Fe/S trafficking models involved in maturation of E. coli 
enzymes, IspG and IspH, based on A-type carriers (Vinella et al., 2009). Therefore, here the suitable 
model composed of ErpA with either human IscA (hISCA1)(Song et al., 2009) or IscA from 
Arabidopsis thaliana (CpIscA)(Abdel-ghany et al., 2005) was re-constructed and expressed in the 
yeast cytosol, which is harboring the bacterial MEP pathway, and their influence on the functionality 
of the pathway was investigated. 
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Figure 17: Schematic representation of Fe-S clusters assembly machinery in S. cerevisiae (details are discussed 
in section 2.7). The dashed arrows represent the apparatuses which are not defined completely yet.   
 
2.6.1. Re-construction of the possible bacterial Fe/S trafficking routes and the bacterial electron 
transfer system 
As an attempt to solve the problem of the non-functionality of the MEP pathway in S. cerevisiae, the 
impact of the co-expression of genes involved in transferring of Fe-S cluster into IspG/IspH, E. coli 
electron transfer system and a copy of ispG and ispH both from A. thaliana on the functionality of 
MEP pathway were investigated. Thus, the coding region of genes including erpA, fpr and fldA from 
E. coli assembled on pISP08 (Figure 18) were transformed into SCISP06 generating SCISP16 (Table 
2.4). The empty plasmid pSP-GM1 was transformed into CEN.PK113-13D and SCISP06 resulting in 
SCISP28 and SCISP29, respectively (Table 2.4). A copy of each ispG and ispH from A. thaliana were 
cloned with iscA from either human or A. thaliana resulting in pISP24 and pISP25, respectively 
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(Figure 18). Strains SCISP31 and SCISP32 were constructed by co-transforming pISP08 with either 
pISP24 or pISP25 into SCISP12, respectively (Table 2.4). 
 
Figure 18: plasmid-based reconstruction of possible Fe/S trafficking routes involved in maturation of bacterial 
IspG/IspH, bacterial electron transfer systems and plant-derived ispG/ispH in S. cerevisiae. 
 
To rule out any possible additional effect on cell growth using lovastatin for inhibition the MVA 
pathway, the functionality of the bacterial MEP pathway was investigated by genetically blocking the 
MVA pathway, which offers promising and absolute inactivation of the MVA pathway. It has been 
indicated that yeast strains with deficiencies in ERG13, ERG19, ERG8, or ERG9 are non-viable under 
normal growth conditions (Servouse et al., 1984; Bergès et al., 1997;
 
Dimster-Denk & Rine, 1996;
 
Tsay & Robinson, 1991;
 
Jennings et al., 1991). Since the MEP pathway contributes to the ergosterol 
biosynthetic pathway through IPP and DMAPP intermediates, deletion of each ERG13, ERG19 or 
ERG8, which are located upstream of these intermediates, should be more efficient than using 
lovastatin for blocking the MVA pathway and evaluating the MEP pathway functionality. For our 
purpose, ERG13 was a good candidate since supplying the medium with exogenous mevalonate can 
complement its inactivation. ERG13 encodes HMG-CoA synthase (Maury et al., 2005), and its 
disruption results in a strain that requires exogenous mevalonate supplementation for viability 
(Dimster-Denk & Rine, 1996). The coding region of ERG13 was replaced by a KanMx integration 
cassette, which was confirmed by PCR (Figure 19). As it is illustrated in Figure 20, the ERG13 
deleted strains could not grow in media lacking mevalonate under aerobic conditions.  
 
Figure 19: Gel electrophoresis of PCR products to confirm deletion of ERG13 (1: SCISP28, 2: SCISP29, 3: 
SCISP16, 4: CEN.PK 113-13D (wild type), 5: SCISP30, 6: SCISP31, 7: SCISP32, M: 1 kb Plus DNA ladder. 
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Figure 20: Aerobic cultivation of MEP pathway. upper panel: strains co-expressing erpA, fpr and fldA; lower 
panel: strains co-expressing erpA, fpr, fldA, At-IspG , At-IspH with either CpIscA or hISCA. All strains were 
erg13 background.  
 
2.6.2. Evaluation of the bacterial MEP pathway in S. cerevisiae under anaerobic condition 
Fe-S clusters are sensitive to superoxide (O2
-
) and other oxidative agents (Liochev & Fridovich, 1994; 
Pantopoulos & Hentze, 1995). The Fe-S cluster contained in IspH is easily destroyed by exposure to 
molecular oxygen or other oxidative agents (Gräwert et al., 2004). Therefore, to prevent inactivation 
of the Fe-S clusters in IspG and IspH, all erg13 strains were also evaluated under anaerobic 
conditions. Yeast growing in anaerobic condition is ergosterol-dependent as the biosynthesis of 
ergosterol is disrupted in this condition. For this, exogenous ergosterol was added to the SD media at a 
final concentration of 1 mg L
-1
. None of the erg13 strains showed mevalonate-independent growth 
(Figure 21). This means that, even in anaerobic conditions, the MEP pathway was not able to 
complement the MVA pathway.  
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Figure 21: Anaerobic cultivation of MEP pathway. upper panel: strains co-expressing erpA, fpr and fldA; lower 
panel: strains co-expressing erpA, fpr, fldA, At-IspG , At-IspH with either CpIscA or hISCA. All strains were 
erg13 background.  
 
Besides demonstrating a strategy for easy integration of eight heterologous genes, here I present 
different strategies in order to make functional MEP pathway in Saccharomyces cerevisiae. My efforts 
can be approached from different angles, which are considered below. However, the results did not 
prove any activity of the MEP pathway.  
First, I constructed possible bacterial paths (aerobic and anaerobic), which have previously been 
proposed and shown transferring of Fe-S clusters into IspG and IspH in E. coli, in yeast cytosol 
(Figure 22) (Vinella et al., 2009). The authors have suggested that, depending on environmental 
conditions, e.g. aerobic, anaerobic or stress, Fe-S cluster is transferred from IscU or SufU scaffolds to 
apoIspG and apoIspH through the combination of A-type carriers, including ErpA, IscA and SufA 
(Vinella et al., 2009). Hence, erpA from E. coli was first expressed to build the direct transferring 
route of Fe/S cluster into IspG and IspH from their scaffold. It was shown that the Fe-S clusters can 
directly be transferred from IscU to ErpA in E. coli (Pinske & Sawers, 2012). I could not obtain 
functionality of the enzymes. Previously reported data have shown that the cytosolic localization has 
failed to generate a functional bacterial or human IscU while expressing in yeast (Gerber et al., 2004). 
Even yeast U-type homolog scaffolds (Isu1 and Isu2) playing a crucial role in maturation of both 
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cytosolic and mitochondrial Fe-S proteins need to be expressed in the mitochondria to show activity 
(Gerber et al., 2004). 
 
Figure 22: Schematic representation of possible Fe/S trafficking routes involved in maturation of bacterial 
IspG/IspH in E. coli (left) and reconstruction of possible routes preformed in this study in the yeast cytosol 
(right). Round dot arrows represent unknown mechanisms for transferring the Fe-S clusters from mitochondria to 
cytosol. For more information see text. 
Furthermore, IscA from either human or A. thaliana were co-expressed with erpA in order to create 
the second and third transferring routes of Fe/S clusters into IspG and IspH from scaffold proteins. 
Previously, localization and activity of human ISCA1 (hISCA1) was shown to be in the cytosol of 
HeLa cells (Song et al., 2009). The authors have also demonstrated interaction of the small domain of 
IOP1 (Iron-only hydrogenase-like protein I) with human ISCA1 using yeast two-hybrid systems 
(Song et al., 2009). CpiscA from A. thaliana is involved in Fe-S biogenesis in chloroplasts (Abdel-
ghany et al., 2005). The Fe-S cluster in CpIspA indicated stability in presence of oxygen (Abdel-ghany 
et al., 2005).  
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Second, the E. coli electron transfer system was reconstructed in yeast by co-expressing fldA encoding 
flavodoxin I and fpr encoding flavodoxin reductase. Puan and co-workers (Puan et al., 2005) identified 
fldA as an essential gene for isoprenoid biosynthesis in E. coli, as it provides reducing equivalents for 
the Fe/S clusters of IspG and IspH (Jenkins & Waterman, 1994). It has been reported that both 
enzymes, IspG and IspH, are dependent on NADPH and the flavodoxin/flavodoxin reductase redox 
system as electron donor for their catalytic activity (Puan et al., 2005;
 
Rohdich et al., 2003;
 
Wolff, 
2003;
  
Seemann et al.,2006;
 
Xiao et al., 2008;
 
Xiao et al., 2009)
.
 Gräwert and co-workers (Gräwert et 
al., 2004) have reported that the in vitro maximum activity for IspH was obtained with NADPH as co-
substrate, together with recombinant flavodoxin and flavodoxin reductase from E.coli. Flavodoxin and 
flavodoxin reductase are FMN and the FAD cofactor containing proteins, respectively, and it has been 
shown that NADPH is the preferred reducing equivalent of flavodoxin reductase compared to NADH 
(Jenkins & Waterman, 1994). Over-expression of flavodoxin and flavodoxin reductase might facilitate 
electron flux from NADPH to IspG and IspH and, therefore, result in increased activity of these 
enzymes. A similar phenomenon was observed in biosynthesis of hydrocortisone in yeast (Szczebara 
et al., 2003). Over-expression of the yeast essential reductase, Arh1 (adrenodoxin reductase homolog), 
using strong promoter increased the production of hydrocortisone up to 60% (Szczebara et al., 2003). 
Both Arh1 and human ADX protein (adrenodoxin) are responsible for transferring electrons from 
NADPH to the related enzyme. The authors have suggested that the flux of electrons was elevated as a 
result of the ARH1 overexpression (Szczebara et al., 2003). 
And finally, due to the above mentioned findings, we also hypothesized that the poor recognition of 
the bacterial apo-proteins, IspG and IspH, by the eukaryotic Fe/S cluster machinery leads to low 
amounts of active proteins and subsequently results in inefficient MEP pathway activity. Thus, the co-
expression of a copy of each ispG and ispH both from A. thaliana was investigated, in order to 
increase the pool of expressed enzymes and, subsequently, to overcome the probable lack of IspG and 
IspH. 
Furthermore, my findings indicate that, despite the presence of Fe-S assembly machineries in yeast, 
the ISC system present in mitochondria and the CIA system for cytosolic Fe-S cluster assembly, 
(Mühlenhoff et al., 2002;
 
Sharma et al., 2010;
 
Lill & Mühlenhoff, 2005) these may not be suitable for 
transferring iron-sulfur clusters to IspG and IspH. In addition, different known and unknown elements 
are involved in transferring the Fe-S clusters from the scaffold to apo-proteins. Some of these elements 
have been identified and isolated and their collaboration in such transmission has been proved in vivo 
(Loiseau et al., 2007; Vinella et al., 2009). In spite of some differences, these elements show similar 
biochemical properties and potential functional redundancy. However, such transmission might be a 
major challenge in order to have a functional MEP pathway in the yeast cytosol.  
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CHAPTER 3: CONCLUSIONS AND PERSPECTIVES 
 
Pathway optimization and, specifically, modulation of the enzyme expression is subjected and one of 
the key challenges in the most metabolic engineering investigations aiming at production of fine 
chemicals and pharmaceuticals. During my PhD study, I have focused on optimizing enzyme activity 
through the modulation of gene dosage and gene copy number in Saccharomyces cerevisiae. 
Furthermore, a new expression system was developed and implemented in optimizing the endogenous 
mevalonate pathway and in re-constructing the heterologous MEP pathway, in order to generate a new 
yeast strain as a microbial cell factory for over-production of isoprenoids.  
Due to advantageous use of glucose, in terms of economy and productivity, a new divergent promoter 
has been developed, containing two strong and constitutive promoters, TEF1 and PGK1. I showed that 
the two promoters, in the bidirectional construct, have expression profiles similar to the corresponding 
isolated promoters and can therefore support high level gene expression. Furthermore, the new 
divergent promoter was used to construct new episomal plasmids, pSP series (Paper I), to optimize the 
endogenous mevalonate pathway through gene integration (Paper IV) and also to construct the 
integration cassettes containing the synthetic MEP pathway (Paper V). Besides, the activities of 7 
different constitutive and glucose based promoters, PTEF1, PTPI1, PTDH3, PADH1, PPGK1, PHXT7 and PPYK1, 
were compared with each other and showed varying profiles of activity for each promoter. However, I 
used PPGK1 and PTEF1 for constructing the new vector, but depending on the purpose one can use 
different promoter pairs with comparable or different expression patterns. As we demonstrated in 
Paper III, using the PHXT1 promoter repressed the ERG9 transcription under glucose limitation in an 
efficient manner as similar to successful implementation of the synthetic posttranscriptional genetic 
tool, RNA control modules (Rnt1p), to reduce the transcription level of the ERG9 gene (Babiskin & 
Smolke, 2011b). Our results in paper III demonstrated pathway optimization through redirection of the 
carbon flux through employing synthetic biology tools at transcription level independent of addition of 
external compounds. In addition, engineering the pSP-G vector by introducing additional restriction 
sites after both terminator regions to generate pSP-GM allowed us simple construction of integration 
cassettes containing 4 genes for optimizing the endogenous mevalonate pathway.   
Modulating gene copy number at DNA level further improved enzyme activity. In paper II, a more 
than 3-fold improvement of the plasmid copy number was demonstrated through the modulation of the 
auxotrophic marker (URA3) level applying two different biological toolsets, a weak promoter leading 
to low transcription level and the ubiquitin-tag/N-degron system alerting the protein stability. 
Combination of both the weak promoter and the ubiquitin-tag/N-degron system indicated positive 
effect on plasmid copy number. Subsequently, I found a high correlation between the plasmid copy 
number and patchoulol production. In addition, in this paper, I reported the successful application of 
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the signal peptide leading to protein-degradation in order to modulate plasmid copy number for the 
first time generating the new 2μm-based episomal plasmid. This expression vector is useful for 
metabolic engineering projects that aim at high level production of valuable products using yeast as a 
production platform. Furthermore, the system described here can potentially be applied to other 
systems using plasmid-based gene expression.  
Paper IV and paper V represent not only the high capacity of yeast for accepting several genetic 
manipulations through either chromosomal integration or plasmid transformation, but also it shows the 
efficiency of the bipartite gene targeting (Erdeniz et al., 1997) in combination with reusable marker for 
such manipulations. In paper IV, the outcomes was showed that introduction of all modifications in 
combination with a specifically developed continuous fermentation process led to a 4-fold 
improvement of α-santalene yield over the reference strain.    
In the last investigation, I demonstrated a strategy for easy and stable integration of the bacterial MEP 
pathway, containing 8 genes in two steps into yeast chromosome and I showed the expression of this 
pathway at the transcription level. However, a Functional MEP pathway was not achieved due to lack 
of enzyme activity. I found that, despite the presence of Fe-S assembly machineries in yeast, the ISC 
system present in mitochondria and the CIA system for cytosolic Fe-S cluster assembly, trafficking of 
Fe-S clusters into the last two enzymes of the MEP pathway is challenging. Inspecting the results 
presented in paper V, I believe that specific physical interaction and compartmentalization would be 
required for in vivo biogenesis and transfer of essential prosthetic groups, here the iron-sulfur clusters 
for activation of bacterial MEP pathway enzymes in yeast. Therefore, it seems interesting to evaluate 
IspG and IspH expression in the mitochondria as this may represent a new interesting engineering 
strategy, which may even be relevant for activation of other bacterial iron-sulfur cluster proteins in 
yeast. 
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